Michele Maio1,2
, Hugues JM Nicolay1,2
, Paolo Ascierto3
, Filippo Belardelli4
, Roberto Camerini5
, Mario P Colombo6
, Paola Queirolo7
, Ruggero Ridolfi8
, Vincenzo Russo9
, Lucia Anzalone1
, Ester Fonsatti1
and Giorgio Parmiani10 
1
Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
2
Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy
3
Unit of Clinical Immunology, Istituto Nazionale Tumori "Fondazione Pascale" Naples, Italy
4
Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
5
Clinical Research Unit III, Sigma Tau SpA, Rome, Italy
6
Immunotherapy and Gene Therapy Unit, Department of Experimental Oncology, Fondazione Istituto Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy
7
Department of Medical Oncology A, National Institute for Cancer Research, Genova, Italy
8
Immunotherapy and Somatic Cell Therapy Unit, Istituto Scientifico Romagnolo per lo studio e la cura dei tumori, Forlì, Italy
9
Cancer Gene Therapy Unit, Department of Oncology, Scientific Institute S. Raffaele, Milan, Italy
10
Department of Oncology, San Raffaele Scientific Institute, Milan, Italy